Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases

Annals of Surgical Oncology

Volumn 8, Issue 5, 2001, Pages 425-431

  Vlastos, Georges ^a   Jean, Marina E ^a   Mirza, Attiqa N ^a   Mirza, Nadeem Q ^a   Kuerer, Henry M ^a   Ames, Frederick C ^a   Hunt, Kelly K ^a   Ross, Merrick I ^a   Buchholz, Thomas A ^a   Buzdar, Aman U ^a   Singletary, S Eva ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Axillary metastasis; Breast neoplasm; Breast preservation; Occult primary

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; NEUROENDOCRINE TUMOR; OCCULT CANCER; SURGICAL APPROACH; TREATMENT OUTCOME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, UNKNOWN PRIMARY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035007068     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-001-0425-6     Document Type: Article

References (38)

1. Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients
2. Treatment of patients with cancer of an unknown primary site
3. The unknown primary presenting with axillary lymphadenopathy
4. Occult carcinoma of the breast
5. Axillary lymph node metastases in patients with occult noninvasive breast carcinoma
6. Axillary lymph node metastasis from an occult breast cancer
7. The results of radical operations for the cure of carcinoma of the breast
8. Some clinical facts regarding mammary cancer
9. Occult breast cancer presenting with axillary metastases: Updated management
10. Management of patients with cancer of unknown primary site
11. Breast conservation for mammographically occult carcinoma
12. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin
13. Breast
14. Ten-year results of FAC adjuvant chemotherapy trial in breast cancer
15. Breast cancer adjuvant therapy at the M.D Anderson Cancer Center: Results of four prospective studies
16. Nonparametric estimation from incomplete observations
17. Occult breast cancer: A case report and review of the literature
18. Clinically occult breast carcinoma: Diagnostic approaches and role of axillary node dissection
19. Occult breast carcinoma presenting with axillary lymph node metastases: A follow-up of 48 patients
20. Axillary nodal metastases from an occult primary consistent with breast carcinomas
21. Axillary metastases from an unknown primary source: A diagnostic and therapeutic approach
22. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor
23. Presentation of axillary lymphadenopathy without detectable primary (T0N1b breast cancer): Experience at Institut Curie
24. Occult primary cancer with axillary metastases
25. Conservative treatment of axillary adenopathy due to probable subclinical breast cancer
26. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons
27. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
28. Improved disease-free and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer
29. Putting taxanes to work in operable breast cancer: A search for selective indications from empirical studies
30. Taxane-based three-drug combination in metastatic and adjuvant treatment of breast cancer
31. Tamoxifen for early breast cancer: An overview of the randomized trials
32. NSABP halts B-14 trial: No benefit seen beyond 5 years of tamoxifen use
33. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: Results from the National Surgical Adjuvant Breast and Bowel Project B-16
34. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients
35. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy
36. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer
37. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer
38. Does administration of chemotherapy prior to radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?